STO · —
CellaVision AB (publ) (CEVI.ST) Stock
$165.80
-1.78%
STO: CEVI.ST
—
—
Valuation
Financials & Margins
Latest News
Early Warning Press Release - FirstLine Venture Partners Corporation Announces Acquisition of Securities of Forward Water Technologies Corp.
TMX Newsfile · Sep 22, 2026
Palantir Gains as Karp Puts Liability Before AI Listings
GuruFocus.com · Sep 22, 2026
Gold Slides as Fed Fears Take Over
GuruFocus.com · Sep 22, 2026
Action Behavior Centers Launches New Career Resource Hub for BCBAs(R) and ABA Therapists
ACCESS Newswire · Sep 22, 2026
Alibaba Just Unveiled an AI Chip 3x Faster Than Its Predecessor. Nvidia Has a China Problem to Watch
Insider Monkey · Sep 22, 2026
Valuation & Return Ratios
Peer Comparison
About CellaVision AB (publ)
—
CellaVision AB (publ) (CEVI.ST) stock trades at $165.80 with a market capitalization of $3.83B. The stock is valued at a price-to-earnings (P/E) ratio of 29.65, price-to-book of 4.32, price-to-sales of 5.18. Over the past 52 weeks the stock has ranged between $117.60 and $192.20, and currently trades 13.7% below its 52-week high. It pays a dividend yielding 1.69%.
On profitability, CellaVision AB (publ) generates a return on equity (ROE) of 15.11%, above the typical market average, an operating margin of 20.61%, a net profit margin of 17.47%.
Official website: www.cellavision.com